AU7386796A - Method for prevention of xenograft rejection by transplant recipients - Google Patents

Method for prevention of xenograft rejection by transplant recipients

Info

Publication number
AU7386796A
AU7386796A AU73867/96A AU7386796A AU7386796A AU 7386796 A AU7386796 A AU 7386796A AU 73867/96 A AU73867/96 A AU 73867/96A AU 7386796 A AU7386796 A AU 7386796A AU 7386796 A AU7386796 A AU 7386796A
Authority
AU
Australia
Prior art keywords
prevention
transplant recipients
xenograft rejection
xenograft
rejection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU73867/96A
Inventor
William M. Baldwin III
Elizabeth A. Davis
Alfred P. Sanfilippo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
School of Medicine of Johns Hopkins University
Original Assignee
Johns Hopkins University
School of Medicine of Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johns Hopkins University, School of Medicine of Johns Hopkins University filed Critical Johns Hopkins University
Publication of AU7386796A publication Critical patent/AU7386796A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU73867/96A 1995-09-28 1996-09-27 Method for prevention of xenograft rejection by transplant recipients Abandoned AU7386796A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US445895P 1995-09-28 1995-09-28
US004458 1995-09-28
PCT/US1996/015838 WO1997011601A1 (en) 1995-09-28 1996-09-27 Method for prevention of xenograft rejection by transplant recipients

Publications (1)

Publication Number Publication Date
AU7386796A true AU7386796A (en) 1997-04-17

Family

ID=21710916

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73867/96A Abandoned AU7386796A (en) 1995-09-28 1996-09-27 Method for prevention of xenograft rejection by transplant recipients

Country Status (2)

Country Link
AU (1) AU7386796A (en)
WO (1) WO1997011601A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9905503D0 (en) 1999-03-10 1999-05-05 Adprotech Plc Novel compound formulations and methods of delivery
CN1327991A (en) * 2000-06-12 2001-12-26 上海博德基因开发有限公司 Polypeptide-complement receptor 12 and polynucleotide for coding it
EP2632476B1 (en) * 2010-10-27 2017-06-14 Celldex Therapeutics, Inc. Method of improving transplant function using soluble complement receptor type i (scr1)

Also Published As

Publication number Publication date
WO1997011601A1 (en) 1997-04-03

Similar Documents

Publication Publication Date Title
AU5219198A (en) Method to prevent transplant rejection
AU6073499A (en) Method to prevent xenograft transplant rejection
AU4494197A (en) Method of preventing acute rejection following solid organ transplantation
AU2053997A (en) Method for the preparation of dialkyl ethers
EP0474280A3 (en) Method for forming thin silicon membrane or beam
AU7662896A (en) Method for the production of hybrid plants
AU4391393A (en) Soft earshell for hearing aids
AU7444996A (en) Improved architecture for voice messaging systems
IL124581A0 (en) Method for adaptive kalman filtering in dynamic systems
AU2639699A (en) Method and apparatus for interference rejection
AU4783293A (en) Method for screening compositions
EP0678344A3 (en) Method for forming water-repellant film
AU3105799A (en) Method for removal of ammonia from fly ash
AU8018991A (en) Method for purifying an inert gas stream
AU633737B2 (en) Method of making steel for springs
AU2323492A (en) Method for inhibiting allograft rejection
AU7386796A (en) Method for prevention of xenograft rejection by transplant recipients
AU7424594A (en) Method for preparing 3-aminopyridines from 3-nitropyridines
AU3835697A (en) Method for inhibiting the growth of mammalian cells
AU7303996A (en) Method for collecting cylindrical bone grafts
AU5346198A (en) Method for preparing zeolites from fly ash
AU9683098A (en) Method for predicting transplant rejection
AU1710095A (en) Method for isolating of wheyproteins
AU5079298A (en) Method for making acetal compounds
AU1752999A (en) Method for preventing transplant rejection